Genetic variants linked to HSCT outcomes in ALLMarch 8, 2017Leukemia, Myelodysplasia, TransplantationTransplantationALL
Single dose of ZA pre-transplant prevents bone lossMarch 1, 2017Leukemia, Myelodysplasia, TransplantationTransplantation
FDA expands approved indication for lenalidomideFebruary 28, 2017Multiple MyelomaPharmacyTransplantation
VZV vaccine reduces HZ incidence after HSCTFebruary 28, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Inpatient palliative care improves QOL for HSCT patientsFebruary 27, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Immunotherapy receives fast track designationFebruary 22, 2017Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Genetic profiling can guide HSCT in MDS, team saysFebruary 10, 2017AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationMyelodysplastic Syndrome
Study reveals CML patients likely to benefit from HSCT long-termDecember 15, 2016Leukemia, Myelodysplasia, TransplantationTransplantationCML
Restrictive transfusion strategy should be standard after HSCT, doc saysDecember 13, 2016Blood BankingTransplantation